CPRX 8-K 2026-07-15

CATALYST PHARMACEUTICALS, INC. (CPRX) 8-K dated 2026-07-15 — accession 0001193125-26-304984. This URL is the filing, not the CPRX hub.

CATALYST PHARMACEUTICALS, INC. (CPRX) is a biotechnology company listed on NASDAQ.

CATALYST PHARMACEUTICALS, INC. filed a 8-K on 2026-07-15. Accession 0001193125-26-304984.

Cached items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.

Not investment advice. The CPRX SEC hub lists recent forms. The stock page is the research view.